Overview
Transitional cell carcinoma (TCC) of the urinary bladder, also known as urothelial bladder cancer (UBC), is a common malignancy characterized by tumors arising from the urothelial lining of the bladder. Treatment strategies vary based on tumor stage, grade, and patient-specific factors.Diagnosis
Endoscopic Assessment: Transurethral resection of bladder tumor (TURBT) is crucial for staging and grading 2.
Pathological Grading: Low-grade vs high-grade tumors differentiated based on histological features 2.
Staging: Noninvasive (Ta, T1) vs muscle-invasive (T2-T4) staging determined by depth of tumor invasion 2.
Imaging: CT, MRI, and chest imaging for staging and assessing metastasis 13.Management
Radical Cystectomy: Primary treatment for muscle-invasive disease 13.
Adjuvant Radiotherapy (ART): Considered for patients with adverse pathologic features (e.g., pT3/4, positive margins) but practice varies; impact on survival needs further evidence 1.
Intravesical Therapy: Post-TURBT instillation of chemotherapy or immunotherapy for non-muscle-invasive disease 12.
Preoperative Assessment: Evaluate serum albumin and ASA score to predict complications and survival 3.Special Populations
Comorbidities: High ASA score independently associated with increased complications and decreased overall survival 3.
No specific data: Limited information on management in pregnancy, pediatrics, or elderly populations from provided abstracts.Key Recommendations
Evaluate Serum Albumin and ASA Score Preoperatively: To predict early complications and survival outcomes (Evidence: Moderate) 3.
Consider Adjuvant Radiotherapy for Adverse Pathologic Features: Despite declining use, ART may benefit patients with pT3/4 or positive margins, though evidence is inconclusive (Evidence: Weak) 1.
Utilize Accurate Endoscopic Assessment for Staging and Grading: Ensure accurate tumor staging and grading through thorough TURBT and photographic evaluation by experienced urologists (Evidence: Moderate) 2.References
1 Bateni ZH, Pearce SM, Zainfeld D, Ballas L, Djaladat H, Schuckman AK et al.. National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013. European urology oncology 2020. link
2 Dekalo S, Matzkin H, Mabjeesh NJ. Can urologists accurately stage and grade urothelial bladder cancer by assessing endoscopic photographs?. Journal of telemedicine and telecare 2018. link
3 Djaladat H, Bruins HM, Miranda G, Cai J, Skinner EC, Daneshmand S. The association of preoperative serum albumin level and American Society of Anesthesiologists (ASA) score on early complications and survival of patients undergoing radical cystectomy for urothelial bladder cancer. BJU international 2014. link